MétaCan
Menu
Back to cohort
Record W4411616564 · doi:10.1016/j.ajo.2025.06.037

Industry Sponsorship and Research Outcomes in A Sample of Landmark Ophthalmology Trials

2025· article· en· W4411616564 on OpenAlexaff
Brendan Tao, Thanansayan Dhivagaran, Fahad Butt, Marko M. Popovic, Edward Margolin, Radha P. Kohly

Bibliographic record

VenueAmerican Journal of Ophthalmology · 2025
Typearticle
Languageen
FieldPharmacology, Toxicology and Pharmaceutics
TopicPharmaceutical industry and healthcare
Canadian institutionsWestern UniversityUniversity of Toronto
Fundersnot available
KeywordsLandmarkOptometrySample (material)OphthalmologyMedicineGeographyCartography

Abstract

fetched live from OpenAlex

PURPOSE: To evaluate ophthalmology trials, with versus without industry sponsorship, on the reporting of outcomes, conclusions, and risk of bias, to evaluate whether they favour the investigational product. DESIGN: Retrospective cohort study. METHODS: We identified a sample of landmark ophthalmology trials (with any publication year) defined as those indexed by 1 of several publicly available sources, including EyeWiki, 1 textbook, the National Institutes of Health, and ophthalmologist-led online sources. A sponsor-favoured intervention was defined as: a) the active treatment in placebo-controlled studies, b) the product produced by the sponsor in head-to-head studies, or c) if both interventions were produced by the sponsor, the intervention with the more recent US Food and Drug Administration approval or recency in clinical trial development. Primary trial results were considered favorable for the industry sponsor if the sponsor-favoured intervention was efficacious, had reduced harms surveillance, or was non-inferior compared to the control arm. The main outcomes were reporting of favourable results, favourable study conclusions, and risk of bias (RoB2 tool). Relative risk (RR) with 95% CIs were calculated to compare the incidence of these outcomes between funding groups. RESULTS: We identified 114 trials, including 50 (43.9%) trials that received industry funding and 64 (56.1%) trials without industry funding. Industry sponsored trials were significantly associated with more frequent reporting of results (RR=1.50 [95% CI: 1.11-2.03], P = .03) and conclusions (RR = 1.64 [95% CI: 1.23-2.17], P = .01) that were favourable to investigational products. Industry-sponsorship was significantly associated with missing outcomes based on RoB2 evaluation (β = 2.33, P = .03), whereas no difference was noted for other domains and the total RoB2 rating. CONCLUSIONS: Among pivotal ophthalmology trials, industry sponsorship was associated with results and conclusions that favoured investigational products compared to non-industry sponsored trials. This disparity was not comprehensively explained by the commonly used RoB2 tool, since both groups did not significantly differ over most domains. Our results support need for transparent research practices and continued critical appraisal of the existing trial literature.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.194
metaresearch head score (Gemma)0.519
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Incentives · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.806
Threshold uncertainty score0.994

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1940.519
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.006
Bibliometrics0.0080.012
Science and technology studies0.0010.002
Scholarly communication0.0050.004
Open science0.0020.003
Research integrity0.0030.002
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.646
GPT teacher head0.656
Teacher spread0.010 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designObservational
DomainIncentives
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAmerican Journal of OphthalmologySame topicPharmaceutical industry and healthcareFrench-language works237,207